A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients

BACKGROUND: Currently, the main goal of cancer research is to increase longevity of patients suffering malignant cancers. The promising results of BCc1 in vitro and vivo experiments made us look into the effect of BCc1 nanomedicine on patients with cancer in a clinical trial. METHODS: The present in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Nanobiotechnology
Main Authors: Hafizi, Maryam, Kalanaky, Somayeh, moaiery, Hassan, Khayamzadeh, Maryam, Noorian, Sajad, Kaveh, Vahid, Gharib, Behrooz, Foudazi, Hossein, Razavi, Mohsen, Jenabian, Arash, Salimi, Saeid, Sereshki, Mohammad Mahdi Adib, Mirzaei, Hamid Reza, Zarghi, Afshin, Fakharzadeh, Saideh, Nazaran, Mohammad Hassan, Akbari, Mohammad Esmaeil
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6458717/
https://ncbi.nlm.nih.gov/pubmed/30971278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-019-0484-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares